Posizioni attive di Eddy Littler
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
ReViral Ltd.
 ReViral Ltd. BiotechnologyHealth Technology ReViral Ltd. specializes in the areas of virology and antiviral therapies. It offers drugs to treat respiratory synctial virus infection. The company was founded by Neil Matthews and Stuart Cockerill in 2011 and is headquartered in Stevenage, the United Kingdom. | Direttore/Membro del Consiglio | 01/10/2016 | - |
| Direttore operativo | 01/06/2019 | - | |
| Amministratore Delegato | 01/10/2016 | 10/06/2019 | |
Domainex Ltd.
 Domainex Ltd. Pharmaceuticals: MajorHealth Technology Domainex Ltd. operates as a drug discovery company. Its services include drug target expression, structural biology, virtual hit screening, medicinal chemistry, computational chemistry, assay development, and fragment based screening. The firm offers combinatorial domain hunting technology, and leadbuilder virtual hit screening software. The company was founded by Laurence Harris Pearl, Renos Savva, Paul Driscoll and Chrisostosmos Prodromou in 2001 and is headquartered in Saffron Walden, the United Kingdom. | Direttore/Membro del Consiglio | - | - |
| Amministratore Delegato | 01/05/2008 | 01/06/2020 | |
| Presidente | 01/06/2020 | - |
Storia della carriera di Eddy Littler
Statistiche
Distribuzione geografica
| Regno Unito | 3 |
Posizioni
| Director/Board Member | 2 |
| Chief Executive Officer | 2 |
| Chief Operating Officer | 1 |
Settori
| Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 2 |
|---|---|
ReViral Ltd.
ReViral Ltd. BiotechnologyHealth Technology ReViral Ltd. specializes in the areas of virology and antiviral therapies. It offers drugs to treat respiratory synctial virus infection. The company was founded by Neil Matthews and Stuart Cockerill in 2011 and is headquartered in Stevenage, the United Kingdom. | Health Technology |
Domainex Ltd.
Domainex Ltd. Pharmaceuticals: MajorHealth Technology Domainex Ltd. operates as a drug discovery company. Its services include drug target expression, structural biology, virtual hit screening, medicinal chemistry, computational chemistry, assay development, and fragment based screening. The firm offers combinatorial domain hunting technology, and leadbuilder virtual hit screening software. The company was founded by Laurence Harris Pearl, Renos Savva, Paul Driscoll and Chrisostosmos Prodromou in 2001 and is headquartered in Saffron Walden, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Eddy Littler
- Esperienza
